Cancer stem cell in breast cancer therapeutic resistance
Breast cancer (BC) is one of the most common cancers responsible for approximately 30% of new female cancer cases and ranked as the 2nd cause of cancer-related deaths in annual statistics [1]. The treatment options for BC, including breast-conserving surgery or mastectomy, radiotherapy (RT), chemotherapy (CT), hormone therapy (HT), and other novel therapies, are decided based on the individual features of clinico-pathology. For instance, mastectomy and adjuvant RT are utilized for many early BCs with curative intent.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Xupeng Bai, Jie Ni, Julia Beretov, Peter Graham, Yong Li Tags: Anti-Tumour Treatment Source Type: research
More News: Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Chemotherapy | Hormonal Therapy | Hormones | Mastectomy | Pathology | Statistics | Stem Cell Therapy | Stem Cells